Yahoo Search Búsqueda en la Web

Entrar

Resultado de búsqueda

  1. www.maunakeatech.com › en › news-eventsMauna Kea Technologies Announces 9 Presentations Demonstrating...

    6 de may. de 2024 · Mauna Kea Technologies Announces 9 Presentations Demonstrating the Clinical Value of Cellvizio® at Digestive Disease Week® 2024. AI, pancreatic cancer and food intolerance headline wide range of Cellvizio abstracts at gastroenterology’s largest international meeting.

  2. Videos

    Ver todo

  3. es.marketscreener.com › cotizacion › accionMauna Kea Technologies SA anuncia la apertura de un Centro de ...

    29 de abr. de 2024 · Mauna Kea Technologies SA ha anunciado la apertura de un Centro de Excelencia francés para el uso de Cellvizio en el diagnóstico del cáncer de pulmón. El procedimiento Cellvizio es ahora realizado de forma preoperatoria por el Prof. Stephane Renaud, MD, PhD, un destacado cirujano torácico del Hospital Universitario (CHRU) de ...

  4. finance.yahoo.com › news › mauna-kea-technologies-announces-9-154500853Mauna Kea Technologies Announces 9 Presentations Demonstrating...

    6 de may. de 2024 · PARIS & BOSTON, May 06, 2024--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser...

  5. www.maunakeatech.com › en › news-eventsMauna Kea Technologies Announces New Clinical Study and Research...

    30 de abr. de 2024 · Mauna Kea Technologies... New research collaboration agreement with the Lung Cancer Initiative (“LCI”) at Johnson & Johnson to advance the validation of Cellvizio as a real-time biopsy guidance tool during robotic-assisted bronchoscopy to potentially reduce the near-miss rate of peripheral lung cancer.

  6. finance.yahoo.com › news › mauna-kea-technologies-announces-opening-154500576Mauna Kea Technologies Announces the Opening of a French Center...

    29 de abr. de 2024 · Mauna Kea Technologies (Euronext Growth: ALMKT) (Paris:ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today...

  7. Imágenes

    • Mauna Kea Receives 14th FDA Clearance For The Cellvizio 100 Series ...
    • Cellvizio Dual Band for in vivo preclinical imaging - Mauna Kea ...
    • Cellvizio Dual Band - Mauna Kea Technologies | accela

    Ver todo

  8. www.businesswire.com › news › homeBusiness Wire - Mauna Kea Technologies Reports Full Year 2023...

    25 de abr. de 2024 · Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today reported its...

  9. www.streetinsider.com › Business+Wire › Mauna+Kea+Technologies+Announces+9Mauna Kea Technologies Announces 9 Presentations Demonstrating...

    6 de may. de 2024 · Mauna Kea Technologies Announces 9 Presentations Demonstrating the Clinical Value of Cellvizio® at Digestive Disease Week® 2024. Article. May 6, 2024 11:45 AM EDT. Tweet Share E-mail. AI,...